Effect of mirtazapine for benzodiazepines use compared with selective serotonin reuptake inhibitors in patients with major depressive disorder: A multicenter, open-label, randomized, controlled trial

被引:0
|
作者
Hashimoto, T. [1 ]
Shiina, A. [2 ]
Hasegawa, T. [2 ]
Kimura, H. [3 ]
Niitsu, T. [1 ]
Tachibana, M. [4 ]
Muneoka, K. [5 ]
Matsuki, S. [1 ]
Nakazato, M. [1 ]
Shiraishi, T. [1 ]
Iyo, M. [1 ]
机构
[1] Chiba Univ, Chiba, Japan
[2] Chiba Univ, Kokoronokenko Clin Tsudanuma, Chiba, Japan
[3] Chiba Univ, Kokoronokaze Clin, Chiba, Japan
[4] Fujita Hosp, Chiba, Japan
[5] Kimura Hosp, Chiba, Japan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:56 / 56
页数:1
相关论文
共 50 条
  • [1] Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial
    Hashimoto, Tasuku
    Shiina, Akihiro
    Hasegawa, Tadashi
    Kimura, Hiroshi
    Oda, Yasunori
    Niitsu, Tomihisa
    Ishikawa, Masatomo
    Tachibana, Masumi
    Muneoka, Katsumasa
    Matsuki, Satoshi
    Nakazato, Michiko
    Iyo, Masaomi
    ANNALS OF GENERAL PSYCHIATRY, 2016, 15
  • [2] Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial
    Tasuku Hashimoto
    Akihiro Shiina
    Tadashi Hasegawa
    Hiroshi Kimura
    Yasunori Oda
    Tomihisa Niitsu
    Masatomo Ishikawa
    Masumi Tachibana
    Katsumasa Muneoka
    Satoshi Matsuki
    Michiko Nakazato
    Masaomi Iyo
    Annals of General Psychiatry, 15
  • [3] A randomized, open-label pilot trial of selective serotonin reuptake inhibitors on neuropsychological functions in patients with obsessive compulsive disorder
    Brar, Jasmine
    Sidana, Ajeet
    Chauhan, Nidhi
    Bajaj, Manoj Kumar
    JOURNAL OF PSYCHIATRIC RESEARCH, 2022, 151 : 439 - 444
  • [4] Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine and venlafaxine, in Korean patients with major depressive disorder
    Jung, Y. -E.
    Jun, T. -Y.
    Kim, K. -S.
    Bahk, W. -M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (07) : 437 - 443
  • [5] Open-Label Placebo for Major Depressive Disorder: A Pilot Randomized Controlled Trial
    Kelley, John M.
    Kaptchuk, Ted J.
    Cusin, Cristina
    Lipkin, Samuel
    Fava, Maurizio
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2012, 81 (05) : 312 - 314
  • [7] Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study
    Cheon, Eun-Jin
    Lee, Kwang-Hun
    Park, Young-Woo
    Lee, Jong-hun
    Koo, Bon-Hoon
    Lee, Seung-Jae
    Sung, Hyung-Mo
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (02) : 193 - 199
  • [8] Selective serotonin reuptake inhibitors:: use in children and adolescents with major depressive disorder
    Jimenez-Arriero, M. A.
    Fernandez, I.
    Vidal, J.
    Herraez, C.
    Parellada, M.
    Cruz, M. A.
    Perez-Cayuela, P.
    Ausejo, M.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2007, 35 (05): : 342 - 350
  • [9] Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial
    Diniz, J. B.
    Shavitt, R. G.
    Pereira, C. A. B.
    Hounie, A. G.
    Pimentel, I.
    Koran, L. M.
    Dainesi, S. M.
    Miguel, E. C.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (03) : 297 - 307
  • [10] Selective Serotonin Reuptake Inhibitors for Cessation of Betel Quid Use in Patients with Major Depressive Disorder in Taiwan
    Hung, Chung-Chieh
    Tu, Hung-Pin
    Chung, Chia-Min
    BIOMEDICINES, 2024, 12 (11)